CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Bicalutamide

比卡鲁胺 杂质对照品Bicalutamide Impurities

EP34 个杂质条目34 impurity entries

本页汇总 比卡鲁胺 的 34 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 34 impurity reference standards of Bicalutamide with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 比卡鲁胺(Bicalutamide)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesDevelopment and validation of a simple and sensitive high performance liquid chromatographic method for the simultaneous determination of anastrozole, bicalutamide, tamoxifen, and their synthetic impurities
    Talanta · 2012 · Gomes FP, Garcia PL  ·  PMID 23158354  ·  DOI
  2. 杂质研究Impurity studiesAnalytical and semipreparative high performance liquid chromatography enantioseparation of bicalutamide and its chiral impurities on an immobilized polysaccharide-based chiral stationary phase
    Journal of chromatography. A · 2016 · Sadutto D et al.  ·  PMID 27067494  ·  DOI
  3. 杂质研究Impurity studiesDevelopment and validation of stability-indicating HPLC and UPLC methods for the determination of bicalutamide
    Journal of chromatographic science · 2012 · Nanduri VV et al.  ·  PMID 22407342  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisOne-Pot Synthesis of β-Hydroxysulfones and Its Application in the Preparation of Anticancer Drug Bicalutamide
    The Journal of organic chemistry · 2017 · Wang Y et al.  ·  PMID 28875700  ·  DOI
  • 合成方法SynthesisMechanistic studies on the synthesis of bicalutamide
    Organic & biomolecular chemistry · 2009 · Asaad N, Fillery S  ·  PMID 19194583  ·  DOI

比卡鲁胺 —— 原料药与杂质对照品Bicalutamide — drug substance & impurities

共 35 个条目(含原料药本体)35 items incl. the drug substance
Bicalutamide structure
EP原料药 APIAPI
比卡鲁胺Bicalutamide
Bicalutamide
CAS No.90357-06-5
Chemical FormulaC18H14F4N2O4S
Purity>95%询价On request
10mg25mg50mg100mg
Bicalutamide Impurity 3(Bicalutamide EP Impurity A) structure
EPA
比卡鲁胺杂质3(比卡鲁胺EP杂质A)Bicalutamide Impurity 3(Bicalutamide EP Impurity A)
Bicalutamide Impurity 3(Bicalutamide EP Impurity A)
CAS No.90357-05-4
Chemical FormulaC18H15F3N2O4S
Purity>95%询价On request
10mg25mg50mg100mg
Bicalutamide Impurity 4(Bicalutamide EP Impurity B) structure
EPB
比卡鲁胺杂质4(比卡鲁胺EP杂质B)Bicalutamide Impurity 4(Bicalutamide EP Impurity B)
Bicalutamide Impurity 4(Bicalutamide EP Impurity B)
CAS No.1159977-36-2
Chemical FormulaC18H14F4N2O4S
Purity>95%询价On request
10mg25mg50mg100mg
Bicalutamide Impurity 5(Bicalutamide EP Impurity C) structure
EPC
比卡鲁胺杂质5(比卡鲁胺EP杂质C)Bicalutamide Impurity 5(Bicalutamide EP Impurity C)
Bicalutamide Impurity 5(Bicalutamide EP Impurity C)
CAS No.906008-94-4
Chemical FormulaC18H14F4N2O3S
Purity>95%询价On request
10mg25mg50mg100mg
Bicalutamide Impurity 6 (Bicalutamide EP Impurity D) structure
EPD
比卡鲁胺杂质6 (比卡鲁胺EP杂质D)Bicalutamide Impurity 6 (Bicalutamide EP Impurity D)
Bicalutamide Impurity 6 (Bicalutamide EP Impurity D)
CAS No.654-70-6
Chemical FormulaC8H5F3N2
Purity>95%询价On request
10mg25mg50mg100mg
Bicalutamide Impurity 12 (Bicalutamide EP Impurity H) structure
EPH
比卡鲁胺杂质12 (比卡鲁胺EP杂质H)Bicalutamide Impurity 12 (Bicalutamide EP Impurity H)
Bicalutamide Impurity 12 (Bicalutamide EP Impurity H)
CAS No.2512198-58-0
Chemical FormulaC18H14F4N2O4S
Purity>95%询价On request
10mg25mg50mg100mg
Bicalutamide Impurity 8(Bicalutamide EP Impurity J) structure
EPJ
比卡鲁胺杂质8(比卡鲁胺EP杂质J)Bicalutamide Impurity 8(Bicalutamide EP Impurity J)
Bicalutamide Impurity 8(Bicalutamide EP Impurity J)
CAS No.90356-78-8
Chemical FormulaC18H14F4N2O2S
Purity>95%询价On request
10mg25mg50mg100mg
Bicalutamide Impurity 15(Bicalutamide EP Impurity M) structure
EPM
比卡鲁胺杂质15(比卡鲁胺EP杂质M)Bicalutamide Impurity 15(Bicalutamide EP Impurity M)
Bicalutamide Impurity 15(Bicalutamide EP Impurity M)
CAS No.151262-57-6
Chemical FormulaC10H11FO5S
Purity>95%询价On request
10mg25mg50mg100mg
Bicalutamide Impurity 1 structure
1
比卡鲁胺杂质1Bicalutamide Impurity 1
Bicalutamide Impurity 1
CAS No.113299-38-0
Chemical FormulaC18H14F4N2O4S
Purity>95%询价On request
10mg25mg50mg100mg
Bicalutamide Impurity 2 structure
2
比卡鲁胺杂质2Bicalutamide Impurity 2
Bicalutamide Impurity 2
CAS No.113299-40-4
Chemical FormulaC18H14F4N2O4S
Purity>95%询价On request
10mg25mg50mg100mg
Bicalutamide Impurity 7 structure
7
比卡鲁胺杂质7Bicalutamide Impurity 7
Bicalutamide Impurity 7
CAS No.945419-64-7
Chemical FormulaC18H14F4N2O3S
Purity>95%询价On request
10mg25mg50mg100mg
Bicalutamide Impurity 9 structure
9
比卡鲁胺杂质9Bicalutamide Impurity 9
Bicalutamide Impurity 9
CAS No.1166228-30-3
Chemical FormulaC18H14F4N2O4S
Purity>95%询价On request
10mg25mg50mg100mg
Bicalutamide Impurity 16 structure
16
比卡鲁胺杂质16Bicalutamide Impurity 16
Bicalutamide Impurity 16
CAS No.90357-51-0
Chemical FormulaC12H9F3N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Bicalutamide Impurity 19 structure
19
比卡鲁胺杂质19Bicalutamide Impurity 19
Bicalutamide Impurity 19
CAS No.90357-53-2
Chemical FormulaC12H9F3N2O
Purity>95%询价On request
10mg25mg50mg100mg
Bicalutamide Impurity 21 structure
21
比卡鲁胺杂质21Bicalutamide Impurity 21
Bicalutamide Impurity 21
CAS No.1839619-50-9
Chemical FormulaC17H8F6N4S
Purity>95%询价On request
10mg25mg50mg100mg
Bicalutamide Impurity 22 structure
22
比卡鲁胺杂质22Bicalutamide Impurity 22
Bicalutamide Impurity 22
CAS No.1483-54-1
Chemical FormulaC8H5F3N2
Purity>95%询价On request
10mg25mg50mg100mg
Bicalutamide Impurity 23 structure
23
比卡鲁胺杂质23Bicalutamide Impurity 23
Bicalutamide Impurity 23
CAS No.58458-11-0
Chemical FormulaC8H5F3N2
Purity>95%询价On request
10mg25mg50mg100mg
Bicalutamide Impurity 24 structure
24
比卡鲁胺杂质24Bicalutamide Impurity 24
Bicalutamide Impurity 24
CAS No.393-36-2
Chemical FormulaC7H5BrF3N
Purity>95%询价On request
10mg25mg50mg100mg
Bicalutamide Impurity 25 structure
25
比卡鲁胺杂质25Bicalutamide Impurity 25
Bicalutamide Impurity 25
CAS No.1217546-57-0
Chemical FormulaC28H26F4N2O7S
Purity>95%询价On request
10mg25mg50mg100mg
Bicalutamide Impurity 26 structure
26
比卡鲁胺杂质26Bicalutamide Impurity 26
Bicalutamide Impurity 26
CAS No.1217519-01-1
Chemical FormulaC28H26F4N2O7S
Purity>95%询价On request
10mg25mg50mg100mg
Bicalutamide Impurity 27 structure
27
比卡鲁胺杂质27Bicalutamide Impurity 27
Bicalutamide Impurity 27
CAS No.113299-39-1
Chemical FormulaC28H26F4N2O7S
Purity>95%询价On request
10mg25mg50mg100mg
Bicalutamide Impurity 28 structure
28
比卡鲁胺杂质28Bicalutamide Impurity 28
Bicalutamide Impurity 28
CAS No.113181-03-6
Chemical FormulaC28H26F4N2O7S
Purity>95%询价On request
10mg25mg50mg100mg
Bicalutamide Impurity 31 structure
31
比卡鲁胺杂质31Bicalutamide Impurity 31
Bicalutamide Impurity 31
CAS No.1080647-25-1
Chemical FormulaC18H14F4N2O3S
Purity>95%询价On request
10mg25mg50mg100mg
Bicalutamide Impurity 33 structure
33
比卡鲁胺杂质33Bicalutamide Impurity 33
Bicalutamide Impurity 33
CAS No.367-67-9
Chemical FormulaC7H3BrF3NO2
Purity>95%询价On request
10mg25mg50mg100mg
Bicalutamide Impurity 34 structure
34
比卡鲁胺杂质34Bicalutamide Impurity 34
Bicalutamide Impurity 34
CAS No.316373-92-9
Chemical FormulaC12H11F3N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Bicalutamide Impurity 35 structure
35
比卡鲁胺杂质35Bicalutamide Impurity 35
Bicalutamide Impurity 35
CAS No.71515-96-3
Chemical FormulaC12H11F3N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Bicalutamide Impurity 36 structure
36
比卡鲁胺杂质36Bicalutamide Impurity 36
Bicalutamide Impurity 36
CAS No.2905-15-9
Chemical FormulaC12H8F2O2S2
Purity>95%询价On request
10mg25mg50mg100mg
Bicalutamide Impurity 37 structure
37
比卡鲁胺杂质37Bicalutamide Impurity 37
Bicalutamide Impurity 37
CAS No.50986-83-9
Chemical FormulaC6H4ClFOS
Purity>95%询价On request
10mg25mg50mg100mg
Bicalutamide Impurity 39 structure
39
比卡鲁胺杂质39Bicalutamide Impurity 39
Bicalutamide Impurity 39
CAS No.143782-18-7
Chemical FormulaC9H3F3N2O
Purity>95%询价On request
10mg25mg50mg100mg
Bicalutamide Impurity 40 structure
40
比卡鲁胺杂质40Bicalutamide Impurity 40
Bicalutamide Impurity 40
CAS No.1080647-26-2
Chemical FormulaC18H14F4N2O3S
Purity>95%询价On request
10mg25mg50mg100mg
Bicalutamide Impurity 41 structure
41
比卡鲁胺杂质41Bicalutamide Impurity 41
Bicalutamide Impurity 41
CAS No.151262-59-8
Chemical FormulaC24H22F4N2O10S
Purity>95%询价On request
10mg25mg50mg100mg
Bicalutamide Impurity 43 structure
43
比卡鲁胺杂质43Bicalutamide Impurity 43
Bicalutamide Impurity 43
CAS No.778-94-9
Chemical FormulaC8H3F3N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Bicalutamide Impurity 44 structure
44
比卡鲁胺杂质44Bicalutamide Impurity 44
Bicalutamide Impurity 44
CAS No.320-47-8
Chemical FormulaC8H3F3N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Bicalutamide Impurity 45 structure
45
比卡鲁胺杂质45Bicalutamide Impurity 45
Bicalutamide Impurity 45
CAS No.1415564-70-3
Chemical FormulaC17H8F6N4S
Purity>95%询价On request
10mg25mg50mg100mg
Bicalutamide Impurity 46 structure
46
比卡鲁胺杂质46Bicalutamide Impurity 46
Bicalutamide Impurity 46
CAS No.2200280-97-1
Chemical FormulaC18H16F4N2O5S
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

比卡鲁胺 —— 研究文献与合成路线Bicalutamide — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 比卡鲁胺 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Bicalutamide. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Isolation and characterization of process related impurities and degradation products of bicalutamide and development of RP-HPLC method for impurity profile study
    Nageswara Rao R, Narasa Raju A, Narsimha R · Journal of pharmaceutical and biomedical analysis · 2008 · 被引 16cited 16
  2. Chemical Degradation of Androgen Receptor (AR) Using Bicalutamide Analog-Thalidomide PROTACs
    Kim GY, Song CW, Yang YS, et al. · Molecules (Basel, Switzerland) · 2021 · 被引 27cited 27
  3. Analytical and semipreparative high performance liquid chromatography enantioseparation of bicalutamide and its chiral impurities on an immobilized polysaccharide-based chiral stationary phase
    Sadutto D, Ferretti R, Zanitti L, et al. · Journal of chromatography. A · 2016 · 被引 12cited 12
  4. Development and validation of a simple and sensitive high performance liquid chromatographic method for the simultaneous determination of anastrozole, bicalutamide, tamoxifen, and their synthetic impurities
    Gomes FP, Garcia PL · Talanta · 2012 · 被引 8cited 8
  5. Macrophage-targeting nano-formulated bicalutamide alleviates colitis by inducing MAP3K1-mediated degradation of NLRP3
    Zhong S, Zhong S, Wu Y, et al. · Journal of controlled release : official journal of the Controlled Release Society · 2025 · 被引 2cited 2

合成与制备工艺专利Synthesis & process patents

  1. PROCESS FOR PREPARING BICALUTAMIDE
    SHRAWAT VIMAL KUMAR, PUROHIT PRASHANT, RAFIUDDIN, RAO KARRI PAPA · 公开号 WO2012042532WO2012042532 · 2012
  2. New process of preparing bicalutamide by utilizing air for oxidizing bicalutamide thioether intermediate
    HUAPING GU, FEI ZHENG · 公开号 CN101817768CN101817768 · 2010
  3. PROCESS FOR PREPARATION OF BICALUTAMIDE
    TARUR VENKATASUBRAMANIAN RADHA, KADAM SURESH MAHADEV, JOSHI ANIL PURUSHOTTAM, GAVHANE SACHIN BABAN · 公开号 KR20070114343KR20070114343 · 2007
  4. New process for preparing epoxide intermediate of Bicalutamide by utilizing air oxidation
    JISHENG BAO, HUAPING GU · 公开号 CN101830869CN101830869 · 2010
  5. Process for preparation of bicalutamide
    SHUKLA ANIL KUMAR, MAIKAP GOLAK CHANDRA, AGARWAL SHIV KUMAR · 公开号 US7544828US7544828 · 2009

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

比卡鲁胺 杂质谱研究要点Bicalutamide — impurity profiling notes

下面这些是拿到 比卡鲁胺 的 35 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 35 impurity entries for Bicalutamide, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances